XML 52 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Current assets    
Cash and cash equivalents $ 961,925 $ 880,601
Marketable securities 285,726 0
Accounts receivable, net 520,960 560,666
Inventories 430,006 525,776
Prepaid expenses and other current assets 18,272 11,807
Deferred income taxes 31,541 32,437
Total current assets 2,248,430 2,011,287
Property, plant and equipment, net 2,916,630 2,757,557
Equity investments 9,593 61,305
Other assets, net    
Intangible assets, net 218,652 218,431
Deferred charges and other assets, net 131,100 165,410
Total other assets, net 349,752 383,841
Total assets 5,524,405 5,213,990
Current liabilities    
Accounts and notes payable 244,772 261,062
Accrued liabilities 290,115 276,118
Total current liabilities 534,887 537,180
Long-term debt 764,086 763,997
Deferred income taxes 534,824 536,066
Other liabilities 170,770 174,859
Total liabilities $ 2,004,567 $ 2,012,102
Commitments and contingencies (Notes 8 and 19)
Stockholders' equity    
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding $ 0 $ 0
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,663,244 and 134,679,064 shares issued at September 30, 2015 and December 31, 2014, respectively 1,347 1,347
Common stock, held in treasury, at cost; 3,722,899 and 1,787,546 shares at September 30, 2015 and December 31, 2014, respectively (217,542) (96,372)
Additional paid-in capital 540,342 530,441
Retained earnings 3,022,717 2,555,528
Accumulated other comprehensive loss (121,865) (79,433)
Total Westlake Chemical Corporation stockholders' equity 3,224,999 2,911,511
Noncontrolling interests 294,839 290,377
Total equity 3,519,838 3,201,888
Total liabilities and equity $ 5,524,405 $ 5,213,990